---
$id: https://graph.org.ai/products/commodity/51171816
$type: Product
source: UNSPSC
code: "51171816"
title: "Ondansetron"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ondansetron

**UNSPSC Code**: 51171816
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula C18H19N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4AF302ESOS, chemically known as 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one but generally known as ondansetron, which bears US NIH Compound Identifier 4595. European Medicines Agency schedules Ondansetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09445MIG. The term ONDANSETRON is an International Non-Proprietary Name. World Health Organization schedules ondansetron in its Anatomical Therapeutic Chemical (ATC) Classification. ONDANSETRON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ondansetron under HS 29332990 and SITC 51573. As of Q4 2014, ONDANSETRON remains the US FDA Preferred Term for this commodity. Ondansetron bears US NLM identifiers UMLS ID C0061851 and NCI Concept Code C1119. SMILES: O=C1C(CCC2N(C3C(C12)CCCC3)C)CN1C(NCC1)C.

